Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association

Authors
Glenn N. Levine, Richard A. Lange, C. Noel Bairey-Merz
Publication
Journal of the American Heart Association
6(10):e002218
Abstract

Provides 37 pages of summaries from decades of research concerning how meditation affects heart related functioning (blood pressure, heart rate, etc.)

Abstract

Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions that can contribute to the primary and secondary prevention of cardiovascular disease are of interest. Numerous studies have reported on the benefits of meditation. Meditation instruction and practice is widely accessible and inexpensive and may thus be a potential attractive cost-effective adjunct to more traditional medical therapies. Accordingly, this American Heart Association scientific statement systematically reviewed the data on the potential benefits of meditation on cardiovascular risk. Neurophysiological and neuroanatomical studies demonstrate that meditation can have long-standing effects on the brain, which provide some biological plausibility for beneficial consequences on the physiological basal state and on cardiovascular risk. Studies of the effects ofmeditation on cardiovascular risk have included those investigating physiological response to stress, smoking cessation, blood pressure reduction, insulin resistance and metabolic syndrome, endothelial function, inducible myocardial ischemia, and primary and secondary prevention of cardiovascular disease. Overall, studies of meditation suggest a possible benefit on cardiovascular risk, although the overall quality and, in some cases, quantity of study data are modest. Given the low costs and low risks of this intervention, meditation may be considered as an adjunct to guideline-directed cardiovascular risk reduction by those interested in this lifestyle modification, with the understanding that the benefits of such intervention remain to be better established. Further research on meditation and cardiovascular risk is warranted. Such studies, to the degree possible, should utilize randomized study design, be adequately powered to meet the primary study outcome, strive to achieve low drop-out rates, include long-term follow-up, and be performed by those without inherent bias in outcome.

Related Listings
Transcendental meditation for lowering blood pr...
Authors
Soo Liang Ooi, Melisa Giovino, Sok Cheon Pak
Journal
Complementary Therapies in Medicine
·
Background Transcendental meditation (TM) is a stress reduction technique that can potentially lower blood pressure (BP) safely. The American Heart Association recommends that TM may be considered in clinical practice. Objective To provide an overview of all systematic reviews and meta-analyses of TM on BP for evidence-informed clinical decision making. Method Systematic searches of PubMed, EBSCOhost, Cochrane Library, Web of Science, Embase, and PsycINFO for all systematic rev […]
Nonpharmacologic Intervention for Hypertension ...
Authors
Jane Leserman, PhD, Eileen M Stuart, RN, MS, Mary E. Mamish, BA, John P. Desckro, RN, MS, Rita J. Beckman, RN, MS, Richard Friedman, PhD, Herbert Benson, MD
Journal
Journal of Cardiopulmonary Rehabilitation
We previously reported reduced blood pressure, psychological symptoms, and other cardiac risk factors in hypertensive patients who participated in a nonpharmacologic, outpatient behavioral program. The present study is a 3 to 5 year follow-up of 59 (60%) of the same patients (who served as their own controls) to assess continued efficacy of the program. At entry into the study, patients had hypertension for a median of 6 years. Therefore, it is unlikely that placebo effect could expla […]
Study of the Therapeutic Effects of Intercessor...
Authors
Jeffrey A. Dusek, PhD, Jane B. Sherwood, RN, BSN, Richard Friedman, PhD, Patricia Myers, BA, Charles F. Bethea, MD, Sidney Levitsky, MD, Peter C. Hill, MD, Manoj K. Jain, MD, Stephen L. Kopecky, MD, Paul S. Mueller, MD, Peter Lam, PhD, Herbert Benson, MD, Patricia L. Hibberd, MD, PhD
Journal
American Heart Journal
Background: The effect of intercessory prayer (IP) on outcome in cardiac cases has been evaluated previously, but results are controversial. The goals of the Study of the Therapeutic Effects of Intercessory Prayer (STEP) are to evaluate the effects of receipt of additional study IP and awareness of receipt of additional study IP on outcomes in patients undergoing coronary artery bypass graft surgery. STEP is not designed to determine whether God exists or whether God does or does not […]